Trial intelligence / Profile preview

Melatonin in Neonatal Sepsis

NCT03295162Phase 2Completed

Start
Nov 2015
Primary completion
Mar 2017
Modality
Small Molecules
01

Overview

A Phase 2 trial of melatonin in neonatal sepsis. Started Nov 2015; status: completed.

02

Drugs

melatonin
03

Conditions

neonatal sepsis

Beyond the preview

Go deeper on NCT03295162.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03295162.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call